ArticleEMBO reports2026
Upregulation of AK7 in ACC-VTA glutamatergic projections contributes to chronic inflammation pain in male mice.
Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Chronic inflammation pain is a complex pathological condition involving multiple mechanisms in both the peripheral and central nervous systems. Growing evidence indicates that an imbalance in central nervous system function plays a crucial role in the progression of chronic pain, yet the underlying neural circuits and molecular targets remain largely unclear. Here we identify the anterior cingulate cortex (ACC) as a key mediator in chronic inflammation pain. Noxious stimulation significantly increases c-Fos expression and calcium activity in both the ACC and the ventral tegmental area (VTA). Upregulation of adenosine kinase 7 (AK7) in ACC glutamatergic neurons emerges as an important factor in pain pathogenesis: interfering with AK7 expression reduces neuronal activity in the ACC and VTA and alleviates pain-related behaviors, while overexpressing AK7 enhances neuronal activity in these regions and exacerbates pain. Further experiments demonstrate that modulating the activity of VTA glutamatergic neurons can correspondingly reverse the effects of AK7 manipulation on pain phenotypes. In summary, our findings demonstrate that upregulation of AK7 in ACC promotes chronic pain through the ACC-VTA neural circuit.
Identifiers
42768120What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.